THC Farmaceuticals, Inc.
THC Farmaceuticals, Inc.
Your view on CBDG
Overview
What the company does, where it operates, and who runs it.
About THC Farmaceuticals, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Ed Rosenthal
- Headquarters
- 7170 East McDonald Drive, Scottsdale, AZ, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Ed Rosenthal
- Headquarters
- 7170 East McDonald Drive, Scottsdale, AZ, US
THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses.
As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah.
The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Farmaceuticals, Inc. was founded in 2008 and is based in Scottsdale, Arizona. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for THC Farmaceuticals, Inc., and the rating behind it. CBDG last traded at $0.04; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for THC Farmaceuticals, Inc.. Starting points for THC Farmaceuticals, Inc.: beta -9.64 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for THC Farmaceuticals, Inc.. THC Farmaceuticals, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for THC Farmaceuticals, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for THC Farmaceuticals, Inc.. THC Farmaceuticals, Inc. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
THC Farmaceuticals, Inc. valued side by side against its closest peers. THC Farmaceuticals, Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold THC Farmaceuticals, Inc., and how their positions are changing. At a $797,790 market value, institutional positions materially move THC Farmaceuticals, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by THC Farmaceuticals, Inc. executives and directors. Shares of THC Farmaceuticals, Inc. have traded between $0.0033 and $0.10 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming THC Farmaceuticals, Inc.. THC Farmaceuticals, Inc. is a $797,790 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming THC Farmaceuticals, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for THC Farmaceuticals, Inc.. Coverage tracks THC Farmaceuticals, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.